Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo

Camlin Fine Sciences Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 21, 2024, 10:21 pm

Market Cap 1,994 Cr.
Current Price 119
High / Low143/80.0
Stock P/E
Book Value 41.2
Dividend Yield0.00 %
ROCE1.31 %
ROE7.08 %
Face Value 1.00
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Camlin Fine Sciences Ltd

Competitors of Camlin Fine Sciences Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
HP Adhesives Ltd 699 Cr. 76.2131/75.334.0 19.20.39 %17.7 %12.6 % 2.00
Haryana Leather Chemicals Ltd 41.8 Cr. 85.2124/48.79.25 87.21.17 %8.96 %7.25 % 10.0
Hardcastle & Waud Mfg Co Ltd 54.4 Cr. 7991,355/44228.5 6630.00 %7.00 %5.98 % 10.0
Grauer & Weil (India) Ltd 4,634 Cr. 102120/58.328.9 19.20.49 %26.1 %19.6 % 1.00
DMCC Speciality Chemicals Ltd 733 Cr. 292380/24555.3 85.40.34 %10.8 %5.68 % 10.0
Industry Average12,153.36 Cr898.8055.54181.120.34%13.12%10.00%6.77

All Competitor Stocks of Camlin Fine Sciences Ltd

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales298327331311381389384483388427420406386
Expenses251276285289326365337428338383381381363
Operating Profit47504623552447555044392523
OPM %16%15%14%7%14%6%12%11%13%10%9%6%6%
Other Income121116211310-8622
Interest71210971019181210102014
Depreciation13121313131614141618191921
Profit before tax28293314120152632816-12-10
Tax %30%45%27%612%33%33%75%61%28%59%25%-72%-47%
Net Profit191624-4271341023312-21-14
EPS in Rs1.211.121.75-0.432.250.960.380.831.530.580.93-1.16-0.70

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales3353745095584895347218921,0491,1871,4121,6821,640
Expenses3063274464743975027058199141,0001,2541,4711,483
Operating Profit2947638492321673135187158211157
OPM %9%13%12%15%19%6%2%8%13%16%11%13%10%
Other Income121099-11412143533-410
Interest17202524243132414842416451
Depreciation14141216172227293344566372
Profit before tax1124355350-6-311758105948044
Tax %64%36%18%-4%28%26%22%82%49%38%36%50%
Net Profit415295536-4-2433065604018
EPS in Rs0.401.613.045.743.71-1.08-2.440.052.504.003.873.321.88
Dividend Payout %62%19%12%8%12%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)275.00%93.33%89.66%-34.55%-111.11%-500.00%112.50%900.00%116.67%-7.69%-33.33%
Change in YoY Net Profit Growth (%)0.00%-181.67%-3.68%-124.20%-76.57%-388.89%612.50%787.50%-783.33%-124.36%-25.64%

Camlin Fine Sciences Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:13%
3 Years:11%
TTM:-2%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-367%
Stock Price CAGR
10 Years:7%
5 Years:15%
3 Years:-7%
1 Year:-7%
Return on Equity
10 Years:4%
5 Years:4%
3 Years:2%
Last Year:-7%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:33 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital991010101212121316161717
Reserves5684125167202359338391585732804848673
Borrowings126150160180331373461539550646801683767
Other Liabilities178126131123126273276290328396425424429
Total Liabilities3693694264796691,0161,0871,2321,4751,7902,0451,9721,885
Fixed Assets8383106140201278272306584601858816721
CWIP1223258145917924215434622
Investments111119115117778823
Other Assets2842623163134426097457408619661,1361,1021,119
Total Assets3693694264796691,0161,0871,2321,4751,7902,0451,9721,885

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +56274672-9-15-98611714551139
Cash from Investing Activity +-19-32-26-66-70-149-2-90-133-249-125-66
Cash from Financing Activity +-21-6-15-7911822633913660-86
Net Cash Flow16-124-1131815-12332-14-13

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow29.00-79.00-87.00-76.00-88.00-299.00-357.00-388.00-404.00-363.00-488.00-590.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days8573745699104868883776665
Inventory Days330145184311277207219204200178255216
Days Payable34913214417111015412711999112129130
Cash Conversion Cycle6685114196266157178173184143192151
Working Capital Days727191109178144143120123103125121
ROCE %24%28%28%24%5%0%7%11%13%10%10%1%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters21.71%21.71%17.65%17.65%17.64%17.64%17.64%16.52%48.03%48.03%48.04%48.03%
FIIs5.01%4.81%10.50%10.74%11.32%10.94%10.18%10.11%1.61%0.99%1.69%1.01%
DIIs19.03%17.88%14.47%14.20%13.53%12.53%12.32%9.31%3.89%3.75%4.55%4.88%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.03%0.00%0.00%0.00%0.00%
Public54.25%55.60%57.37%57.42%57.52%58.88%59.82%64.01%46.46%47.22%45.73%46.07%
No. of Shareholders51,03856,39455,27757,83557,90454,19752,92152,27857,09862,09858,16562,687

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Smallcap Fund4,283,1361.1670.2282,0172024-11-185122.25%
HSBC Small Cap Equity Fund - OLD400,0002.096.2882,0172024-11-18387.7%
ICICI Prudential Dividend Yield Equity Fund224,0820.153.6782,0172024-11-18173.21%
Motilal Oswal Nifty Microcap 250 Index Fund82,0170.351.3482,0172024-11-180%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue1.001.001.001.001.00
Basic EPS (Rs.)-5.583.454.654.132.50
Diluted EPS (Rs.)-5.503.414.563.682.50
Cash EPS (Rs.)-1.576.517.428.605.17
Book Value[Excl.RevalReserv]/Share (Rs.)48.2948.1843.2647.8137.67
Book Value[Incl.RevalReserv]/Share (Rs.)50.9752.2548.5255.6737.67
Revenue From Operations / Share (Rs.)96.32107.0489.9593.1186.52
PBDIT / Share (Rs.)5.3413.4411.8414.6611.06
PBIT / Share (Rs.)0.649.468.2711.198.36
PBT / Share (Rs.)-5.935.125.998.244.80
Net Profit / Share (Rs.)-6.262.533.855.132.46
NP After MI And SOA / Share (Rs.)-5.543.323.874.002.50
PBDIT Margin (%)5.5412.5513.1615.7412.78
PBIT Margin (%)0.678.839.1912.019.65
PBT Margin (%)-6.154.776.668.855.54
Net Profit Margin (%)-6.502.364.285.502.84
NP After MI And SOA Margin (%)-5.753.094.294.292.88
Return on Networth / Equity (%)-11.356.929.169.437.58
Return on Capital Employeed (%)0.8911.7210.7714.2014.76
Return On Assets (%)-4.752.523.373.432.45
Long Term Debt / Equity (X)0.400.540.580.500.52
Total Debt / Equity (X)0.801.040.940.991.22
Asset Turnover Ratio (%)0.800.460.480.520.58
Current Ratio (X)1.371.371.501.661.23
Quick Ratio (X)0.660.650.870.990.68
Inventory Turnover Ratio (X)1.381.291.651.791.97
Interest Coverage Ratio (X)1.483.615.204.983.11
Interest Coverage Ratio (Post Tax) (X)0.081.852.692.741.69
Enterprise Value (Cr.)2050.952685.652687.502251.73959.50
EV / Net Operating Revenue (X)1.271.601.901.900.91
EV / EBITDA (X)22.9212.7214.4612.057.15
MarketCap / Net Operating Revenue (X)0.921.191.551.500.45
Price / BV (X)1.832.663.313.301.19
Price / Net Operating Revenue (X)0.921.191.551.500.45
EarningsYield-0.060.020.020.020.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Camlin Fine Sciences Ltd as of November 21, 2024 is: 44.63

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 21, 2024, Camlin Fine Sciences Ltd is Overvalued by 62.50% compared to the current share price 119.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Camlin Fine Sciences Ltd as of November 21, 2024 is: 42.16

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 21, 2024, Camlin Fine Sciences Ltd is Overvalued by 64.57% compared to the current share price 119.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -5.54%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has shown consistent growth in sales (339.77 cr) and profit (41.08 cr) over the years.
  1. The stock has a low average ROCE of 13.42%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 116.67, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 158.75, which may not be favorable.
  4. The company has higher borrowings (443.62) compared to reserves (412.62), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Camlin Fine Sciences Ltd:
    1. Net Profit Margin: -6.5%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 0.89% (Industry Average ROCE: 13.12%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: -11.35% (Industry Average ROE: 10%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 0.08
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.66
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 0 (Industry average Stock P/E: 55.54)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.8
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361. Currently company belongs to the Industry of Chemicals - Others. Company’s Total Operating Revenue is Rs. 685.51 Cr. and Equity Capital is Rs. 15.70 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersFloor 2 to 5, In GS Point, CST Road, Kalina, Mumbai Maharashtra 400098secretarial@camlinfs.com
https://www.camlinfs.com
Management
NamePosition Held
Mr. Ashish DandekarChairman & Managing Director
Mr. Nirmal MomayaManaging Director
Mr. Arjun DukaneExecutive Director -Technical
Mr. Mahabaleshwar PalekarIndependent Director
Mr. Pradip KanakiaIndependent Director
Mr. Amol ShahIndependent Director
Mr. Sutapa BanerjeeIndependent Director
Mr. Joseph Conrad D'souzaIndependent Director
Ms. Anagha DandekarNon Exe.Non Ind.Director
Mr. Harsha RaghavanNon Exe.Non Ind.Director

FAQ

What is the latest intrinsic value of Camlin Fine Sciences Ltd?

The latest intrinsic value of Camlin Fine Sciences Ltd as on 21 November 2024 is ₹44.63, which is 62.50% lower than the current market price of ₹119.00.

What is the Market Cap of Camlin Fine Sciences Ltd?

The Market Cap of Camlin Fine Sciences Ltd is 1,994 Cr..

What is the current Stock Price of Camlin Fine Sciences Ltd as on 21 November 2024?

The current stock price of Camlin Fine Sciences Ltd as on 21 November 2024 is ₹119.

What is the High / Low of Camlin Fine Sciences Ltd stocks in FY 2024?

In FY 2024, the High / Low of Camlin Fine Sciences Ltd stocks is 143/80.0.

What is the Stock P/E of Camlin Fine Sciences Ltd?

The Stock P/E of Camlin Fine Sciences Ltd is .

What is the Book Value of Camlin Fine Sciences Ltd?

The Book Value of Camlin Fine Sciences Ltd is 41.2.

What is the Dividend Yield of Camlin Fine Sciences Ltd?

The Dividend Yield of Camlin Fine Sciences Ltd is 0.00 %.

What is the ROCE of Camlin Fine Sciences Ltd?

The ROCE of Camlin Fine Sciences Ltd is 1.31 %.

What is the ROE of Camlin Fine Sciences Ltd?

The ROE of Camlin Fine Sciences Ltd is 7.08 %.

What is the Face Value of Camlin Fine Sciences Ltd?

The Face Value of Camlin Fine Sciences Ltd is 1.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Camlin Fine Sciences Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE